You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 14, October 10, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •CME Course for This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetic Disorders
 •Genetics, Other
 •Ophthalmology
 •Macular Degeneration
 •Aging/ Geriatrics
 •Alert me on articles by topic

CLINICIAN'S CORNER
Personalized Medicine in the Era of Genomics

Wylie Burke, MD, PhD; Bruce M. Psaty, MD, PhD

JAMA. 2007;298:1682-1684.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Enthusiastic predictions about personalized medicine have surrounded the sequencing of the human genome. As commonly used, the term predicts a leap forward in disease prevention and drug treatment, based on knowledge of individual genetic susceptibilities.1-2 According to Guttmacher and colleagues, "genomics-based knowledge and tools promise the ability to approach each patient as the biological individual he or she is, thereby radically changing our paradigms and improving efficacy."3 Some emerging tests support this promise: mutations in the BRCA1 and BRCA2 genes identify women who have a high lifetime risk for breast and ovarian cancer4 and who are candidates for breast magnetic resonance imaging screening5 or prophylactic surgery.6 Similarly, many pharmacogenetic tests are under development as a means to improve the safety and efficacy of drug treatment.7 In each case, the useful application of a genetic test is linked to an . . . [Full Text of this Article]

Genetic Risk Prediction

Author Affiliations: Center for Genomics and Healthcare Equality and Departments of Medical History and Ethics and Medicine (Dr Burke) and Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Service and the Health Service Center for Health Studies, Group Health (Dr Psaty), University of Washington, Seattle.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

From Genetics to Genomics: Ethics, Policy, and Parental Decision-making
Wilfond and Ross
J Pediatr Psychol 2008;0:jsn075v1-jsn075.
ABSTRACT | FULL TEXT  

The Rise and Impending Decline of Screening Mammography
Hall
Radiology 2008;247:597-601.
FULL TEXT  

Perspective on the future use of genomics in exercise prescription
Roth
J. Appl. Physiol. 2008;104:1243-1245.
FULL TEXT  

The Genetics Revolution and Primary Care Pediatrics
Cheng et al.
JAMA 2008;299:451-453.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.